QC
PHVS icon

Quadrature Capital’s Pharvaris PHVS Stock Holding History

Quadrature Capital’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,723
Closed -$388K – 1953
2026
Q1 		$388K Sell
13,723
-15,197
-53% -$406K ﹤0.01% 880
2025
Q4 		$803K Buy
+28,920
New +$697K 0.01% 576

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Quadrature Capital's PHVS Position: Q2 2026 in Review

Quadrature Capital sold out of Pharvaris (PHVS) in Q2 2026, closing a stake of 13,723 shares — an estimated $388K sold.

Quadrature Capital first reported a position in PHVS in Q4 2025 and held it in 2 quarters. The position peaked at $803K in Q4 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Quadrature Capital reported no remaining Pharvaris position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 13,723 Pharvaris shares in Q2 2026, an estimated $388K.
  • Quadrature Capital first reported a position in Pharvaris in Q4 2025 and held it in 2 quarters.
  • Quadrature Capital's Pharvaris position peaked at $803K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.